Literature DB >> 3264225

Neopterin estimation compared with the ratio of T-cell subpopulations in persons infected with human immunodeficiency virus-1.

D Fuchs1, M Banekovich, A Hausen, J Hutterer, G Reibnegger, E R Werner, F D Gschnait, M P Dierich, H Wachter.   

Abstract

We measured neopterin, a biochemical indicator for the activation of cell-mediated immune reactions, in urines from 105 individuals at risk of infection with human immunodeficiency virus-1 (HIV-1), 83 of whom were seropositive for antibody to HIV-1. We compared absolute numbers of T-cell subsets (CD4+ helper/inducer T-cells, CD8+ suppressor/cytotoxic T-cells), and the ratio of CD4+ T-cells to CD8+ T-cells with the urinary neopterin concentrations. Concentrations of neopterin in urine were inversely correlated with absolute numbers of CD4+ T-cells and with CD4+/CD8+ ratios in anti-HIV-1 seropositive subjects but not in those seronegative. Various statistical comparisons of the data further demonstrated that neopterin concentrations showed larger differences between anti-HIV-1 seronegative and seropositive subjects than absolute numbers of CD4+ T-cells or CD4+/CD8+ ratios. These results seem to indicate that neopterin concentrations increase earlier in the course of HIV-1 infection, before effects on T-cell subpopulations are detectable, and may further support the suggestion that neopterin measurement could be of use for monitoring infected subjects or predicting the progression of disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264225

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Urinary neopterin concentrations and T-cell subset data in HIV-1 infection.

Authors:  G Reibnegger; D Fuchs; J J Goedert; A Hausen; A Krämer; E R Werner; G Werner-Felmayer; M P Dierich; H Wachter
Journal:  Klin Wochenschr       Date:  1990-01-04

2.  Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2.

Authors:  B R Gundlach; H Linhart; U Dittmer; S Sopper; S Reiprich; D Fuchs; B Fleckenstein; G Hunsmann; C Stahl-Hennig; K Uberla
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 3.  Neopterin as a biomarker of immune response in cancer patients.

Authors:  Bohuslav Melichar; Martina Spisarová; Marie Bartoušková; Lenka Kujovská Krčmová; Lenka Javorská; Hana Študentová
Journal:  Ann Transl Med       Date:  2017-07

Review 4.  Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.

Authors:  D Fuchs; A Krämer; G Reibnegger; E R Werner; M P Dierich; J J Goedert; H Wachter
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 5.  Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.

Authors:  B N Stretcher
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

6.  Neopterin in tuberculous and neoplastic pleural fluids.

Authors:  M F Baganha; A Mota-Pinto; M A Pêgo; M A Marques; M A Rosa; A J Cordeiro
Journal:  Lung       Date:  1992       Impact factor: 2.584

7.  vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys.

Authors:  J Hoch; S M Lang; M Weeger; C Stahl-Hennig; C Coulibaly; U Dittmer; G Hunsmann; D Fuchs; J Müller; S Sopper
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 8.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.